- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Beta Drugs Ltd is engaged in manufacturing of a wide range of oncology (anti-cancer) drugs in India. It has operations in the domestic and export markets.
Beta Drugs' board approved its FY26 Director's Report and set the AGM for Sept 30, 2026. M/s Khurana Sharma & Co was re-appointed as Statutory Auditor. Whole-Time Director Ashutosh Shukla's 5-year re-appointment with revised pay received board approval, pending shareholder nod.